Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Vera Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/23/2023 |
4
| Lin Celia (Chief Medical Officer) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Sold 1,490 shares
@ $16.6547, valued at
$24.8k
|
|
| 08/23/2023 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Sold 1,490 shares
@ $16.6558, valued at
$24.8k
|
|
| 08/23/2023 |
4
| Fordyce Marshall (President and CEO) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Sold 5,210 shares
@ $16.6562, valued at
$86.8k
|
|
| 07/06/2023 |
4
| Young Joseph R (SVP, Finance, Chief Acct Offcr) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $3.9396, valued at
$39.4k
|
|
| 05/12/2023 |
4
| SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $7.7, valued at
$154k
|
|
| 05/12/2023 |
4
| MORRISSEY MICHAEL (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $7.7, valued at
$154k
|
|
| 05/12/2023 |
4
| Morrison Scott W (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $7.7, valued at
$154k
|
|
| 05/12/2023 |
4
| Katabi Maha (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $7.7, valued at
$154k
|
|
| 05/12/2023 |
4
| Hall Kimball (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $7.7, valued at
$154k
|
|
| 05/12/2023 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $7.7, valued at
$154k
|
|
| 04/03/2023 |
4
| SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 2,300 shares
@ $7.2395, valued at
$16.7k
|
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 74,045 shares
@ $7.1157, valued at
$526.9k
Bought 15,252 shares
@ $7.2143, valued at
$110k
|
|
| 03/17/2023 |
4
| SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 32,844 shares
@ $7.1249, valued at
$234k
Bought 60,097 shares
@ $7.093, valued at
$426.3k
|
|
| 03/07/2023 |
4
| SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $7.245, valued at
$7.2k
|
|
| 02/27/2023 |
4
| SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 200 shares
@ $7.235, valued at
$1.4k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
4
| SEIDENBERG BETH C (Director) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 46,163 shares
@ $7.24, valued at
$334.2k
Bought 131,602 shares
@ $7.03, valued at
$925.2k
Bought 87,956 shares
@ $7.08, valued at
$622.7k
Bought 45,357 shares
@ $7.22, valued at
$327.5k
|
|
| 02/08/2023 |
4
| Longitude Capital Partners IV, LLC (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 1,714,285 shares
@ $7, valued at
$12M
|
|
| 02/08/2023 |
4
| ENRIGHT PATRICK G (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 1,714,285 shares
@ $7, valued at
$12M
|
|
| 02/08/2023 |
3
| Longitude Prime Partners, LLC (10% Owner) has filed a Form 3 on Vera Therapeutics, Inc. |
| 02/08/2023 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 285,714 shares
@ $7, valued at
$2M
|
|
| 02/08/2023 |
4
| Young Joseph R (SVP, Finance, Chief Acct Offcr) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Bought 5,714 shares
@ $7, valued at
$40k
|
|
| 02/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Sold 6,900 shares
@ $18.2498, valued at
$125.9k
Sold 11,733 shares
@ $18.2767, valued at
$214.4k
Sold 1,078 shares
@ $18.19, valued at
$19.6k
Exercised 6,900 options to buy
@ $11, valued at
$75.9k
Exercised 11,733 options to buy
@ $11, valued at
$129.1k
Exercised 1,078 options to buy
@ $6.3728, valued at
$6.9k
|
|
| 12/08/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Sold 494 shares
@ $16.47, valued at
$8.1k
|
|
| 11/21/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Sold 1,078 shares
@ $15.8606, valued at
$17.1k
Sold 2,211 shares
@ $15.8436, valued at
$35k
Exercised 1,078 options to buy
@ $6.3728, valued at
$6.9k
Exercised 2,211 options to buy
@ $2.8968, valued at
$6.4k
|
|
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Fordyce Marshall (President and CEO) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Sold 11,369 shares
@ $20.385, valued at
$231.8k
Sold 2,408 shares
@ $21.159, valued at
$51k
Sold 6,899 shares
@ $20.2886, valued at
$140k
Sold 10,418 shares
@ $21.6926, valued at
$226k
Sold 906 shares
@ $22.1863, valued at
$20.1k
Exercised 13,777 options to buy
@ $2.8968, valued at
$39.9k
Exercised 18,223 options to buy
@ $2.8968, valued at
$52.8k
|
|
| 09/22/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Sold 978 shares
@ $20.5442, valued at
$20.1k
Sold 100 shares
@ $21, valued at
$2.1k
Sold 1,828 shares
@ $20.4757, valued at
$37.4k
Sold 334 shares
@ $20.9153, valued at
$7k
Sold 2,314 shares
@ $20.241, valued at
$46.8k
Sold 10,112 shares
@ $20.8045, valued at
$210.4k
Sold 910 shares
@ $21.1255, valued at
$19.2k
Sold 264 shares
@ $22.3465, valued at
$5.9k
Exercised 1,078 options to buy
@ $6.3728, valued at
$6.9k
Exercised 2,162 options to buy
@ $2.8968, valued at
$6.3k
Exercised 12,426 options to buy
@ $11, valued at
$136.7k
|
|
| 09/14/2022 |
4
| Fordyce Marshall (President and CEO) has filed a Form 4 on Vera Therapeutics, Inc.|
Txns:
| Sold 10,163 shares
@ $20.784, valued at
$211.2k
Sold 12,200 shares
@ $21.4761, valued at
$262k
Exercised 22,363 options to buy
@ $2.8968, valued at
$64.8k
|
|
| 09/13/2022 |
4/A
| Fordyce Marshall (President and CEO) has filed a Form 4 on Vera Therapeutics, Inc. |
|
|
|